mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.27 |
3e-09 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-09 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.32 |
7e-09 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-09 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-08 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-08 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-08 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-08 |